AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

Nov 4, 2013

30339_dirs_2013-11-04_3a18ff25-05b3-44c9-9a48-e4837a373de3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-02-19

Reporting Person: Bedwell Warwick (President, Pharma Pkgs Systems)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-19	Common Stock	A	2518.0000	$59.1100	Acquired	3166.0000	Direct
2013-02-19	Common Stock	A	1081.0000	$59.1100	Acquired	4247.0000	Direct

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2010 that have vested for performance period 9.

F2: Amended Form 4 to account for taxes withheld from original share acquisition number which was not provided when original Form 4 was filed. Original number of 3,148 shares now reflects the tax withholding of 630 shares for a total acquisition of 2,518 shares.

F3: Bonus and incentive shares granted on 02/19/2013.

F4: Grant not previously recorded on Form 4.